Skip to main content
Equibles
SPRO $1.21 +4.31%
SPRO logo
SPRO · Spero Therapeutics, Inc.
Track SPRO — free

Use SPRO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SPRO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.21 +0.05 (+4.31%)
Rebalance outlook locked
Market Cap
$71.63M
Shares
58.23M
Volume · Oct 5 942.72K Avg daily vol (3M) 1.19M
All webcasts

Earnings call · FY2024 Q4

Spero Therapeutics, Inc. (SPRO) Q4 2024 Earnings Call

Concluded Mar 27, 2025
Mar 27, 2025 0 turns
Period
FY2024 Q4
Runtime
—
Sources
2 artifacts
8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue · derived Q4 $15.04M -79.5% YoY
Net income · derived Q4 -$20.89M -140.8% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Mar 27, 2025 10-K report Filed Mar 27, 2025 Company webcastOpen the original investor-relations page
Full-screen source Call document

SPRO transcript alerts

Spero Therapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →